510(k) Report

510(k) · Cleared

Cleared

Fenzian Treatment System

K041575510(k) TraditionalCleared Jul 16, 200432-day reviewClass II21 CFR 882.5890

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Eumedic Limited · GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

Cleared on Jul 16, 2004 as substantially equivalent to K951951 (Empi, 1996) after a 32-day review. Its family tree reaches back 1 generation to 1996. 12 later devices descend from it.

Decided
Jul 16, 2004
Review
32 days
Class
Class II
Product code
GZJ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K951951 (1996). 12 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2005: 1 descendant cleared2007: 3 descendants cleared2014: 3 descendants cleared2006: 1 descendant cleared2010: 1 descendant cleared2008: 1 descendant cleared2011: 1 descendant cleared2025: 1 descendant clearedK951951 · Focus Model 795 Unit · Empi · 19961995200020052010201520202025
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 7 descendants3 generations forward: 3 descendants K951951 · Focus Model 795 Unit · Empi · 19960
  1. Root · 1 generation backK951951 Focus Model 795 UnitEmpi · 1996
  2. This deviceK041575 Fenzian Treatment SystemEumedic Limited · 2004
  3. Descendant · cites it directly · 10 of its ownK042912 INTERX5000Neuro Resource Group, Inc. · 2005 · Recalled
  4. Descendant · 2 generations on · 2 of its ownK062641 Body-Stim, Biomodulator, Best-Rsi, Best Pro, Model Best-AV1Avazzia, Inc. · 2007 · Recalled
  5. Descendant · 2 generations on · 1 of its ownK133779 CP Relief WandMid-America Medical Innovations, LLC · 2014
  6. Descendant · 2 generations on · 1 of its ownK092117 Scenar, Model 10Ritm Okb Zao · 2010
  7. Descendant · 2 generations on · 1 of its ownK070217 Interx 1000/Derma 200 Stimulator for Cosmetic UseNeuro Resource Group, Inc. · 2008

Showing 5 of 12 descendants. See all descendants

Descendants cleared per year

2005: 12006: 12007: 32008: 12010: 12011: 12014: 32025: 1
2005high 3 (2007) · low 0 (2009)2026

Most influential descendants

Showing 5 of 12 · See all
  • K042912INTERX5000Neuro Resource Group, Inc. · 2005 · cites it directly10descendants
  • K062641Body-Stim, Biomodulator, Best-Rsi, Best Pro, Model Best-AV1Avazzia, Inc. · 2007 · 2 generations on2descendants
  • K133779CP Relief WandMid-America Medical Innovations, LLC · 2014 · 2 generations on1descendant
  • K092117Scenar, Model 10Ritm Okb Zao · 2010 · 2 generations on1descendant
  • K070217Interx 1000/Derma 200 Stimulator for Cosmetic UseNeuro Resource Group, Inc. · 2008 · 2 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K951951Focus Model 795 UnitEmpi1996—
0 (this device)K041575Fenzian Treatment SystemEumedic Limited2004—
+1K042912INTERX5000Neuro Resource Group, Inc.20051
+2K062641Body-Stim, Biomodulator, Best-Rsi, Best Pro, Model Best-AV1Avazzia, Inc.20073
+2K133779CP Relief WandMid-America Medical Innovations, LLC2014—
+2K092117Scenar, Model 10Ritm Okb Zao2010—
+2K070217Interx 1000/Derma 200 Stimulator for Cosmetic UseNeuro Resource Group, Inc.2008—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200510
200610
200730
200810
201010
201110
201430
202510
FIG. 1 — Lineage of K041575, 1996–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GZJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GZJ device

  1. #1 K252767 actiTENS miniscore 13.1 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K951951Focus Model 795 Unit
Summary page 2
…Transcutaneous Electrical Nerve Stimulator Classification 882.5890 TENS SE Predicate: Empi Focus 795 K951951 882.5890 Device Description: The Fenzian Treatment System is an electrical device designed for use…
Empi1996—

Also cleared against K951951: 5 other devices →

What descends from it? (12)

See all 12

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K042912INTERX5000Neuro Resource Group, Inc.200510
K062616Wellnesspro 2010Intelsource Group, Inc.20070

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K042912 (Neuro Resource Group, Inc., 2005) has gone furthest, with 10 descendants of its own.
  • 5 other devices also cite its predicate K951951.

How does its category compare?

All GZJ devices

GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GZJ

1in 2025

2007: 132008: 112009: 162010: 52011: 52012: 122013: 22014: 42015: 32016: 32017: 32018: 22019: 32020: 42021: 32022: 42023: 12024: 32025: 12026 (partial year): 2
2007high 16 (2009) · low 1 (2023)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GZJ

207in 2024

2007: 223 days median2008: 136 days median2009: 155 days median2010: 232 days median2011: 168 days median2012: 154 days median2014: 344 days median2015: 202 days median2016: 163 days median2017: 113 days median2019: 156 days median2020: 183 days median2021: 231 days median2022: 175 days median2024: 207 days median
2007high 344 (2014) · low 113 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GZJ

1in 2011

2007: 42008: 12011: 1
2007high 4 (2007) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GZJ

13in 2025

2007: 42008: 452009: 172010: 222011: 222012: 202013: 102014: 232015: 182016: 322017: 582018: 212019: 72020: 102021: 52022: 42023: 392024: 122025: 13
2007high 58 (2017) · low 4 (2007)2025

MAUDE reports naming product code GZJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071322344
200811136145
200916155017
20105232022
20115168122
201212154020
20132—010
20144344023
20153202018
20163163032
20173113058
20182—021
2019315607
20204183010
2021323105
2022417504
20231—039
20243207012
20251—013
20262—0—

What is it indicated for?

TENS applications:

* Symptomatic relief and management of chronic, intractable pain

* Adjunctive treatment for post-surgical and post-trauma acute pain

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K041575: Fenzian Treatment System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K041575

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026